Rosiglitazone: An Agent from the Thiazolidinedione Class for the Treatment of Type 2 Diabetes

Angela Cheng-Lai, Anne Levine

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint Dive into the research topics of 'Rosiglitazone: An Agent from the Thiazolidinedione Class for the Treatment of Type 2 Diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences